Portage Biotech Inc (PRTG) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2023 and for the year 2025, average high and low, overall ranking from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Portage Biotech Inc   (NASDAQ: PRTG)


Portage Biotech Inc's ROI from its fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Portage Biotech Inc's ROI in the fourth quarter of 2025?
Portage Biotech Inc recorded a cumulative net loss of $-20 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -512.92%.

Within the Healthcare sector 911 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 4495 to 4620.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2024)
IV. Quarter
Y / Y Investment Change TTM -94.05 % -95.7 % -83.04 % -73.54 % -66.07 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1 11 3 1 5
Return On Investment (TTM) -512.92 % -1082.13 % -197.79 % -117.03 % -76.3 %
PRTG's Overall Ranking # 4620 # 4495 # # #
Seq. Investment Change TTM -19.35 % -79.72 % -46.01 % -32.66 % -41.66 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -20 -53 -48 -52 -50

PRTG Company Profile >> Back to PRTG Roi Comparisons >> See Annual PRTG Return On Investment



Return On Investment PRTG's Ranking
Within: No.
Industry # 449
Sector # 912
Overall # 4620

Return On Investment Statistics
High Average Low
-2.13 %
-124.72 %
-602.49 %
(Mar 31 2019)   (Mar 31 2025)







Financial Statements
Portage Biotech Inc's IV. Quarter Investments $ 1 Millions PRTG's Balance sheet
Portage Biotech Inc's IV. Quarter Income $ -7 Millions Quarterly PRTG's Income Statement
PRTG's Income by Division See PRTG's Income by Division


PRTG Annual Return On Investment (Mar 31 2025)
2025		 (Mar 31 2024)
2023		 (Mar 31 2022)
2022		 (Mar 31 2021)
2021		 (Mar 31 2020)
2020
Total Investments in Millions 1 88 194 172 171
Y / Y Investment Growth -98.71 % -54.85 % 12.95 % 0.61 % 1 %
Net Income in Millions -7 -105 -19 -17 -7
Y / Y Net Income Growth - - - - -
Annual Return On Investment -602.49 % -119.58 % -9.89 % -10.01 % -4.25 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PRTG's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PRTG's Competitors
Subscribers only: Roi for Portage Biotech Inc's Suppliers
Subscribers only: Return On Investment for PRTG's Customers

Other Ratios
PRTG's Roa PRTG's Inventory Turnover Ratio PRTG's Growth Rates PRTG's Dividend Statistics
PRTG's Profitability Ratios PRTG's Asset Turnover Ratio PRTG's Dividend Growth
PRTG's Roe PRTG's Valuation Ratios PRTG's Financial Strength Ratios PRTG's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2025, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.